LEGN Legend Biotech Corporation ADRs

Legend Biotech is a clinical stage biopharmaceutical company engaged in the discovery and development of novel cell therapies in hematology/oncology, infectious diseases and auto-immune disorders. Legend operates in the USA, mainland China and Ireland. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$26.43  -0.75 (-2.76%)
As of 03/01/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Mid cap
Health Care
Biotechnology
China

01/02/2015
132,006,304
377,860
$3,488,926,615
0.00%
SEC Edgar Online
20-F
52490G102
US52490G1022
BMX9K07

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-9.21
10.42
64.20
-113.06%
-696.73%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy